HSP90AB1 and cancer: Penisuloxazin A showed antiproliferative activity against various cancer cells, indicating that the type inhibitor is worthy of being studied in the future.456,457 Compared with HSP90 NTD inhibitors, targeting HSP90 CTD does not induce the HSR.